|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,419.00 CHF | +0.50% |
|
+4.96% | +8.65% |
| Feb. 05 | Swiss Market Index Retreats; Gurit Shares Rise | MT |
| Feb. 05 | Barry Callebaut to invest EUR 250 mln in Wieze plant | RE |
| Fiscal Period: August | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.02 | 5.38 | 5.15 | 4.79 | 3.2 | |||||
Return on Total Capital | 7.07 | 8.03 | 8.63 | 9.17 | 5.4 | |||||
Return On Equity % | 15.26 | 12.91 | 15.28 | 6.65 | 6.89 | |||||
Return on Common Equity | 15.25 | 12.92 | 15.33 | 6.62 | 6.81 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 15.92 | 15.04 | 15.92 | 13.31 | 9.69 | |||||
SG&A Margin | 7.89 | 7.24 | 7.89 | 6.39 | 4.88 | |||||
EBITDA Margin % | 10.05 | 9.9 | 9.75 | 10.27 | 5.91 | |||||
EBITA Margin % | 8.1 | 8.03 | 7.92 | 8.73 | 4.83 | |||||
EBIT Margin % | 8.01 | 7.99 | 7.88 | 8.71 | 4.81 | |||||
Income From Continuing Operations Margin % | 5.33 | 4.46 | 5.23 | 1.84 | 1.27 | |||||
Net Income Margin % | 5.33 | 4.46 | 5.25 | 1.83 | 1.26 | |||||
Net Avail. For Common Margin % | 5.33 | 4.46 | 5.25 | 1.83 | 1.26 | |||||
Normalized Net Income Margin | 4.14 | 4.07 | 4.04 | 4.2 | 1.41 | |||||
Levered Free Cash Flow Margin | 3.01 | 3.21 | 2.21 | -19.08 | -0.18 | |||||
Unlevered Free Cash Flow Margin | 3.82 | 4.04 | 3.12 | -17.75 | 1.5 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1 | 1.08 | 1.05 | 0.88 | 1.06 | |||||
Fixed Assets Turnover | 4.07 | 4.4 | 4.72 | 5.78 | 7.96 | |||||
Receivables Turnover (Average Receivables) | 16.52 | 15.67 | 15.69 | 14.56 | 13.9 | |||||
Inventory Turnover (Average Inventory) | 3.07 | 3.08 | 2.66 | 2.11 | 2.58 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.98 | 1.53 | 1.32 | 1.37 | 1.79 | |||||
Quick Ratio | 0.84 | 0.54 | 0.31 | 0.26 | 0.67 | |||||
Operating Cash Flow to Current Liabilities | 0.29 | 0.17 | 0.08 | -0.23 | -0.01 | |||||
Days Sales Outstanding (Average Receivables) | 22.09 | 23.29 | 23.27 | 25.13 | 26.26 | |||||
Days Outstanding Inventory (Average Inventory) | 119.05 | 118.66 | 137.15 | 173.73 | 141.59 | |||||
Average Days Payable Outstanding | 45.48 | 52.64 | 56.17 | 46.21 | 48.15 | |||||
Cash Conversion Cycle (Average Days) | 95.65 | 89.31 | 104.25 | 152.66 | 119.71 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 88.99 | 71.58 | 62.03 | 168.79 | 236.27 | |||||
Total Debt / Total Capital | 47.09 | 41.72 | 38.28 | 62.8 | 70.26 | |||||
LT Debt/Equity | 80.24 | 52.49 | 39.21 | 114.52 | 171.37 | |||||
Long-Term Debt / Total Capital | 42.45 | 30.59 | 24.2 | 42.61 | 50.96 | |||||
Total Liabilities / Total Assets | 62.93 | 62.58 | 65.64 | 81.25 | 79.22 | |||||
EBIT / Interest Expense | 6.13 | 5.97 | 5.41 | 4.09 | 1.79 | |||||
EBITDA / Interest Expense | 8.16 | 7.83 | 7.09 | 5.06 | 2.34 | |||||
(EBITDA - Capex) / Interest Expense | 5.75 | 5.62 | 5.37 | 3.9 | 1.66 | |||||
Total Debt / EBITDA | 3.11 | 2.45 | 2.06 | 4.28 | 6.69 | |||||
Net Debt / EBITDA | 1.68 | 1.39 | 1.46 | 3.4 | 4.63 | |||||
Total Debt / (EBITDA - Capex) | 4.42 | 3.42 | 2.71 | 5.56 | 9.43 | |||||
Net Debt / (EBITDA - Capex) | 2.39 | 1.93 | 1.93 | 4.41 | 6.53 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 4.56 | 12.27 | 4.68 | 22.62 | 42.39 | |||||
Gross Profit, 1 Yr. Growth % | 7.85 | 6.1 | 10.79 | 2.5 | 3.65 | |||||
EBITDA, 1 Yr. Growth % | 12.01 | 10.62 | 4.88 | 29.08 | 9.04 | |||||
EBITA, 1 Yr. Growth % | 14.27 | 11.3 | 5.37 | 35.2 | 11.13 | |||||
EBIT, 1 Yr. Growth % | 15.05 | 11.94 | 5.53 | 35.42 | 11.23 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 23.44 | -6.13 | 22.77 | -56.91 | -1.34 | |||||
Net Income, 1 Yr. Growth % | 21.48 | -6.05 | 23.19 | -57.29 | -2.06 | |||||
Normalized Net Income, 1 Yr. Growth % | 16.51 | 10.25 | 6.78 | 27.4 | -23.09 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 21.55 | -5.99 | 23.21 | -57.26 | -2.17 | |||||
Accounts Receivable, 1 Yr. Growth % | 25.19 | 12.9 | -2.73 | 67.81 | 38.12 | |||||
Inventory, 1 Yr. Growth % | 6.99 | 18.75 | 20.57 | 92.17 | -15.7 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 11.08 | -2.66 | -2.39 | 2.87 | 3.84 | |||||
Total Assets, 1 Yr. Growth % | 1.44 | 7.14 | 8.66 | 79.77 | -16.59 | |||||
Tangible Book Value, 1 Yr. Growth % | 23.36 | 11.51 | 3.23 | 0.74 | -9.98 | |||||
Common Equity, 1 Yr. Growth % | 13.99 | 8.17 | -0.2 | -1.96 | -7.65 | |||||
Cash From Operations, 1 Yr. Growth % | 3.72 | -15.27 | -36.63 | -724.39 | -97.94 | |||||
Capital Expenditures, 1 Yr. Growth % | -2.67 | 5.42 | -11.55 | 21.21 | 5.2 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -42.42 | 21.06 | -25.48 | -1.16K | -98.75 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -37.09 | 18.74 | -17.12 | -797.75 | -111.02 | |||||
Dividend Per Share, 1 Yr. Growth % | 27.27 | 0 | 3.57 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -0.7 | 8.35 | 8.41 | 13.29 | 32.13 | |||||
Gross Profit, 2 Yr. CAGR % | -2.11 | 6.97 | 8.42 | 6.57 | 3.07 | |||||
EBITDA, 2 Yr. CAGR % | -1.53 | 11.31 | 6.8 | 16.36 | 2.88 | |||||
EBITA, 2 Yr. CAGR % | -2.54 | 12.78 | 7.17 | 19.37 | 3.16 | |||||
EBIT, 2 Yr. CAGR % | -2.45 | 13.49 | 7.55 | 19.55 | 3.24 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 2.12 | 7.64 | 7.35 | -27.27 | -34.8 | |||||
Net Income, 2 Yr. CAGR % | 1.83 | 6.83 | 7.58 | -27.46 | -35.33 | |||||
Normalized Net Income, 2 Yr. CAGR % | 1.34 | 13.34 | 7.1 | 16.64 | -21.97 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 1.94 | 6.9 | 7.63 | -27.43 | -35.33 | |||||
Accounts Receivable, 2 Yr. CAGR % | 3.91 | 18.88 | 4.79 | 27.76 | 52.24 | |||||
Inventory, 2 Yr. CAGR % | 6.44 | 12.72 | 19.66 | 52.22 | 27.28 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 11.54 | 3.98 | -2.52 | 0.2 | 3.35 | |||||
Total Assets, 2 Yr. CAGR % | 5.5 | 4.25 | 7.89 | 39.76 | 22.45 | |||||
Tangible Book Value, 2 Yr. CAGR % | 10.86 | 17.29 | 7.29 | 1.97 | -4.77 | |||||
Common Equity, 2 Yr. CAGR % | 5.74 | 11.04 | 3.9 | -1.08 | -4.84 | |||||
Cash From Operations, 2 Yr. CAGR % | 5.25 | -6.25 | -26.72 | 98.91 | -64.14 | |||||
Capital Expenditures, 2 Yr. CAGR % | 2 | 1.29 | -3.44 | 3.54 | 12.92 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 49.9 | -16.97 | -6.58 | 180.95 | -62.11 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 550.01 | -13.57 | -2.08 | 140.5 | -8.45 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.77 | 12.82 | 1.77 | 1.77 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.23 | 3.45 | 7.11 | 12.95 | 22.26 | |||||
Gross Profit, 3 Yr. CAGR % | -0.29 | 0.55 | 8.23 | 6.41 | 5.58 | |||||
EBITDA, 3 Yr. CAGR % | 1.05 | 2.37 | 8.51 | 13.77 | 3.54 | |||||
EBITA, 3 Yr. CAGR % | 0.51 | 1.87 | 9.48 | 15.8 | 3.9 | |||||
EBIT, 3 Yr. CAGR % | 0.56 | 2.13 | 9.99 | 16.14 | 4 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 2.47 | -0.71 | 12.47 | -20.81 | -19.49 | |||||
Net Income, 3 Yr. CAGR % | 2.54 | -0.87 | 12.03 | -20.93 | -19.83 | |||||
Normalized Net Income, 3 Yr. CAGR % | 0.59 | 4.23 | 10.15 | 13.49 | -13.37 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 2.66 | -0.77 | 12.08 | -20.89 | -19.83 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.68 | 6.82 | 11.19 | 22.6 | 31.12 | |||||
Inventory, 3 Yr. CAGR % | 11.43 | 10.39 | 15.28 | 40.13 | 25.01 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.48 | 6.59 | 1.81 | -0.76 | 1.4 | |||||
Total Assets, 3 Yr. CAGR % | 7.49 | 6.04 | 5.7 | 27.91 | 17.67 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.7 | 11.08 | 12.4 | 5.06 | -2.18 | |||||
Common Equity, 3 Yr. CAGR % | 5.73 | 6.55 | 7.16 | 1.91 | -3.32 | |||||
Cash From Operations, 3 Yr. CAGR % | 6.1 | -2.09 | -17.73 | 49.67 | -56.64 | |||||
Capital Expenditures, 3 Yr. CAGR % | 7.91 | 3.13 | -3.18 | 4.16 | 4.09 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -2.47 | 39.08 | -20.79 | 109.88 | -52.52 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -2.02 | 268.82 | -15.51 | 88.43 | -11.43 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.27 | 2.5 | 9.65 | 1.18 | 1.18 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.54 | 3.52 | 4.04 | 7.28 | 16.49 | |||||
Gross Profit, 5 Yr. CAGR % | 5.85 | 4.89 | 3.11 | 2.92 | 6.14 | |||||
EBITDA, 5 Yr. CAGR % | 7.19 | 7.09 | 3.31 | 7.38 | 6.22 | |||||
EBITA, 5 Yr. CAGR % | 7.12 | 7.1 | 3.12 | 8.09 | 6.91 | |||||
EBIT, 5 Yr. CAGR % | 7.33 | 7.62 | 3.3 | 8.31 | 7.24 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 11.92 | 5.12 | 4.4 | -12.33 | -9.57 | |||||
Net Income, 5 Yr. CAGR % | 12.08 | 5.16 | 4.53 | -12.51 | -10.07 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.88 | 9.79 | 3.15 | 8.46 | -4.04 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.11 | 5.23 | 4.62 | -12.45 | -10.05 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.12 | 6.02 | 2.3 | 14.75 | 26.08 | |||||
Inventory, 5 Yr. CAGR % | 4.7 | 13.66 | 14.65 | 25.53 | 19.94 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 8.12 | 5.55 | 4.51 | 3.99 | 2.43 | |||||
Total Assets, 5 Yr. CAGR % | 5.13 | 7.26 | 7.65 | 18.43 | 12.1 | |||||
Tangible Book Value, 5 Yr. CAGR % | 10.4 | 9.69 | 8.73 | 7.34 | 5.19 | |||||
Common Equity, 5 Yr. CAGR % | 6.52 | 6.57 | 4.99 | 3.43 | 2.19 | |||||
Cash From Operations, 5 Yr. CAGR % | -0.19 | -5.27 | -8.5 | 30.01 | -40.98 | |||||
Capital Expenditures, 5 Yr. CAGR % | 7.31 | 5.93 | 3.22 | 3.29 | 2.96 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -7.33 | -11.25 | -4.34 | 83.04 | -41.02 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -6.67 | -9.59 | -2.05 | 209.22 | -12.75 | |||||
Dividend Per Share, 5 Yr. CAGR % | 12.56 | 6.96 | 3.86 | 2.21 | 5.68 |
- Stock Market
- Equities
- BARN Stock
- Financials Barry Callebaut AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















